Initially, such mutations have been uncovered in benign epithelial odontogenic tumors wherein BRAF and KRAS mutations were revealed in ameloblastomas and adenomatoid odontogenic tumors, respectively [9, 11]. Here, KRAS is linked to ameloblastoma.